MedPath

The evaluation of the effect of dexmedetomidine added to local infiltration of bupivacaine on post-operative pain of pediatric inguinal herniorraphy.

Phase 2
Conditions
Inguinal hernia.
Inguinal hernia
Registration Number
IRCT2016060314372N8
Lead Sponsor
Vice Chancellor for Research, Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Patients between the range of 6 months to 6 years old; (ASA I); patients who have surgery for unilateral inguinal hernia.

Exclusion criteria:

A history of bleeding disorders, allergies to Dexmedetomidine and bupivacaine; developmental delay; upper respiratory tract infection, congenital heart disease, liver and kidney failure, neurological disease, mental retardation.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Post-operative pain. Timepoint: children's and infant's postoperative pain scale (CHIPPS). Method of measurement: Immediately after arriving in recovery, 1 hour, 2 hours, 3 hours and 4 hours after surgery.
Secondary Outcome Measures
NameTimeMethod
Sedation. Timepoint: Immediately after arriving in recovery, 1 hour, 2 hours, 3 hours and 4 hours after surgery. Method of measurement: Sedation score.
© Copyright 2025. All Rights Reserved by MedPath